Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Actin, beta (ACTB) (Middle Region) Peptide

ACTB Reactivity: Human Host: Synthetic BP, WB, IHC
Catalog No. ABIN972858

Quick Overview for Actin, beta (ACTB) (Middle Region) Peptide (ABIN972858)

Target

beta Actin (ACTB) (Actin, beta (ACTB))

Origin

Human

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein Region

    Middle Region

    Sequence

    TMKIKIIAPP ERKYSVWIGG SILASLSTFQ QMWISKQEYD ESGPSIVHRK

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-ACTB Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    beta Actin (ACTB) (Actin, beta (ACTB))

    Background

    This protein is one of six different actin proteins. Actins are highly conserved proteins that are involved in cell motility, structure, and integrity. This actin is a major constituent of the contractile apparatus and one of the two nonmuscle cytoskeletal actins.

    Alias Symbols: BRWS1, PS1TP5BP1

    Protein Size: 375

    Molecular Weight

    42 kDa

    Gene ID

    60

    NCBI Accession

    NM_001101, NP_001092

    UniProt

    P60709
You are here:
Chat with us!